Reprogramming to recover youthful epigenetic information and restore vision
Yuancheng Lu, Benedikt Brommer, Xiao Tian, Anitha Krishnan, Margarita Meer, Chen Wang, Daniel L. Vera, Qiurui Zeng, Doudou Yu, Michael S. Bonkowski, Jae-Hyun Yang, Songlin Zhou, Emma M. Hoffmann, Margarete M. Karg, Michael B. Schultz, Alice E. Kane, Noah Davidsohn, Ekaterina Korobkina, Karolina Chwalek, Luis A. Rajman, George M. Church, Konrad Hochedlinger, Vadim N. Gladyshev, Steve Horvath, David A. Sinclair
Do you know what happens on a cellular level when we age? At the core of this process is a complex biological shift that scientists are still trying to understand. Aging is not driven by a single factor, but by many overlapping changes in how cells regulate their genes.
One key process involved in aging is DNA methylation, a chemical tagging system that helps control which genes are switched on or off. As we age, the tagging system can become less precise, disrupting normal cellular function and reducing the ability of tissues to repair and regenerate. Researchers explored whether aspects of this decline could be partially reset in mice. They activated a small set of genes known as the Yamanaka factors, which are capable of shifting cells toward a more youthful genetic state.
In mouse models of age-related vision loss and glaucoma, this approach improved the function of retinal cells and led to measurable improvements in visual performance. The findings suggest that, under carefully controlled conditions, it may be possible to restore some cellular functions that are typically lost with age.
Importantly, this work is still at a preclinical stage. It was conducted in animal models, and significant challenges remain before any potential translation to human therapies, including safety and delivery.
Despite this, the study adds to a growing body of evidence that aging is not simply a one-way and permanent decline. Instead, aspects of cellular aging may be more flexible than previously thought, opening new directions for regenerative medicine and age-related disease research.
